Prelude Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.33

+0.40 (+8.11%)

As of Jun 30, 10:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +76.7% upside

Low Target $6.99

Average Target $9.42

High Target $10.52

Current Price $5.33

Current
$5.33

Target
$9.42

$6.99 $9.42 avg $10.52

Scenario Analysis

Bear Case

$6.99

31.1%

Low target

Base Case

$9.42

+76.7%

Avg target

Bull Case

$10.52

+97.4%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$5.54

-3.8% from high

52-Week Low

$0.75

+610.7% from low

Target vs 52W High

$9.42

+70.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%